← All trials
NCT02380625
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2015
- Primary completion
- Jan 1, 2016
- Completion date
- Mar 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Clinical Research Management, Inc.Lead sponsor
- Duke UniversityOverall official - principal investigator
- Duke UniversityCollaborator
- INC ResearchCollaborator
- University of North Carolina at Chapel HillCollaborator
- Bill and Melinda Gates FoundationCollaborator
- University of Sierra LeoneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.